Compare Novo Nordisk A/S (NVO) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Old Dominion Freight Line Inc — how do they compare? Novo Nordisk A/S trades at $46.32 (market cap $207.85B), while Old Dominion Freight Line Inc trades at $209.64 (market cap $43.43B). The key difference: Novo Nordisk A/S is far larger — about 4.8× Old Dominion Freight Line Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| NVO | ODFL | |
|---|---|---|
Market Cap | $207.85B | $43.43B |
Sector | Health | Industrials |
52-Week High | $63.98 | $248.73 |
52-Week Low | $35.29 | $126.29 |
Enterprise Value | $222.55B | $43.17B |
Dividend Yield | 3.81% | 0.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $46.465, down 2.65% today, with a neutral technical signal. The stock shows strong fundamentals, including a P/E of 11.62, net income margin of 35.35%, and consistent earnings beats in recent quarters. Recent news highlights competitive pressures from Eli Lilly and mixed investor reactions to Q2 2026 results, despite an upwardly revised full-year outlook.
Outlook remains positive due to robust GLP-1 drug demand and profitability, but risks include pricing pressure and competition. Analysts are predominantly bullish (57.9% buy ratings), supporting a favorable long-term view despite near-term volatility.
ODFL trades at $212.58, showing minimal daily movement with a 0.01% gain. The stock demonstrates strong fundamental performance with consistent earnings beats and robust profitability metrics including 19.44% net income margin and 24.82% ROE. Recent Q2 2026 earnings of $1.68 per share exceeded expectations by 9%, driven by yield improvements and cost discipline. Technical indicators show bearish momentum with the price trading near pivot point resistance at $213.
The outlook remains positive given ODFL's operational excellence and pricing power, though premium valuation at 40.28 P/E requires flawless execution. Key risks include freight volume pressures and economic sensitivity. Analyst consensus targets $239.85, suggesting 13% upside potential from current levels, supported by the company's strong balance sheet and dividend payments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
